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Acrylamide has recently been found in a range of heat treated food items. As it is a neurotoxic agent and a probable, human
carcinogen (IARC 2A), human exposure to this chemical might constitute an important public health issue. The purpose of the
study was to estimate the acrylamide intake in Flemish adolescents (based on 7-day food record) and to evaluate the possible health
risks due to the exposure. The Belgian Federal Agency for the Safety of the Food Chain collected 150 food items from diﬀerent
supermarkets and restaurants to analyse the acrylamide level. The limit of quantitation was 30lg acrylamide/kg foodstuﬀs. Expo-
sure modelling was based on Monte Carlo simulations. The estimated dietary intake of acrylamide per person given as the 5th, 50th
and 95th percentile were 0.19, 0.51 and 1.09lg/kgbw/d. Bread, despite its low acrylamide content, is relevant as a source of acryl-
amide exposure at the lower percentiles. At higher percentiles the contribution of French fries and crisps is more important. It must
be emphasised that the exposure assessment has several limitations. Risk of neurotoxicity seems negligible. The relevance of current
intake levels in terms of cancer risk remains a subject of debate.
 2004 Elsevier Ltd. All rights reserved.
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that have been heated at high temperatures (SNFA,
2002b). These included crisps, French fries, bread
and crisp breads. Acrylamide may be formed through
the Maillard reaction from amino acids and reducing
sugars (Mottram et al., 2002; Stadler et al., 2002).
Acrylamide has been shown to be neurotoxic in hu-
mans and laboratory animals (FAO/WHO, 2002;
IARC, 1994). It has been classiﬁed as a Group 2A car-
cinogen by the International Agency for Research on
Cancer (IARC, 1994). This might represent a
potential threat to public health (European Commis-
sion, 2002a; FAO/WHO, 2002). In view of this, the
FAO/WHO Expert Consultation urges more research
on acrylamide in food. It includes formal research, sur-
veillance/monitoring and industry investigations (FAO/
WHO, 2002). Against that background a post-hoc
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database.
The purpose of the current study was to estimate the
acrylamide intake in a Belgian subpopulation, namely
Flemish adolescents and to evaluate the possible health
risks due to this exposure. In the present communica-
tion, a risk assessment of acrylamide intake is described
and discussed.2. Material and methods
2.1. Sampling and chemical analysis
In 2003, the Belgian Federal Agency for the Safety of
the Food Chain collected 150 food items from diﬀerent
supermarkets and restaurants. The samples comprised
babys biscuits, bread, small bread type, crisps, choco-
late, choco-spread, French fries, coﬀee, breakfast cere-
als, gingerbread, sweet spiced biscuit, biscuits and
popcorn. The choice of food items was based on what
was known end of 2002–early 2003 on the occurrence
of acrylamide in foodstuﬀs (FAO/WHO, 2002; FOD
VVVL, 2002; Norwegian Food Agency, 2002; SNFA,
2002a; van Donkersgoed et al., 2002), priority was given
to food groups that, in those studies, had been shown to
contain relevant amounts of acrylamide.
The acrylamide analysis was carried out by a Beltest
accredited laboratory of the Department of Pharmaco-
Bromatology of the Scientiﬁc Institute of Public Health
in Brussels, by using a validated method according to
the ISO 17025 standards. In the experimental procedure
acrylamide is extracted from food with water before a
clean-up of the extract on Solid Phase Extraction com-
bining Oasis HLB and BondElut Accucat cartridges as
described in the US FDA methodology (www.cfsan.
fda.gov). A further concentration step by evaporation
was introduced before analysis using the LC–MS–MS
technique. The limits of the method are respectively
15 and 30lg acrylamide/kg foodstuﬀ for detection
and quantitation. The acrylamide content of coﬀee
was partially determined on the basis of coﬀee powder
and was recalculated to coﬀee drink using a conversion
factor of 0.046 proposed by Dooren et al. (1995). Also
liquid coﬀee was analysed. For the intake estimation,
levels of acrylamide below the limit of quantitation
were set at one third of that limit (4 samples < limit
of quantitation). No data were available on the acryl-
amide content of rusk, therefore the authors used
Dutch contamination data with a reporting limit of
60lg/kg (Konings et al., 2003). Other food groups,
which were not analysed because they are not known
to contain acrylamide, were supposed to contain no
acrylamide at all.
Due to the restricted number of analyses a major
assumption was made: acrylamide contents of analysedfood items were also applied to a number of related food
items for which no analytical data were available. Food
items were considered related when a similar type of
food technology was used to produce them, e.g., salty
crisps and sweet and sour crisps. The type and amount
of amino acid and reducing sugar of the related products
were not considered. Although the acrylamide levels
vary among product categories and within categories
(Petersen, 2002; Svensson et al., 2003), we assumed that
diﬀerences between food items of a certain food group
would be small.
2.2. Exposure estimation
We started from a food intake survey carried out in
Spring 1997, the most recent, detailed dietary survey
available for Belgium (Matthys et al., 2003). That survey
was based on a representative sample of 341 adolescents
(129 boys and 212 girls), aged 13–18 years, from the
region of Ghent (±250,000 inhabitants) in the Dutch-
speaking part of Belgium. Diﬀerent educational op-
tions—classical education (mainly theoretical courses)
and vocational training (based on practical skills)—were
proportionally represented in the sample. A 7-day esti-
mated food record method (semi-structured diary) was
used to quantify food and nutrient intake. Instructions
for the completion of the diary and regular checks for
quality and completeness of the diaries were carried
out by experienced dieticians. The storage of data on in-
take of individual food items was very detailed and con-
tained altogether 745 diﬀerent food items. Although the
adolescent survey was conducted in 1997, it was as-
sumed that the current intake of relevant acrylamide
containing foods has not substantially changed since
1997.
Weight of the respondents was measured according
to the standardised method proposed by the WHO
(World Health Organization, 1995). Data on measured
weights were completed in the same period (within one
week) as the food diary.
Dietary exposure distributions for acrylamide were
generated in a probabilistic way for the total adolescent
population and for boys and girls separately, using a so-
called one-dimensional Monte Carlo simulation pro-
gramme (see Fig. 1) (Cullen and Frey, 1999; Petersen,
2000).
In this approach, a distribution of food consumption
from the target population and available distributions of
acrylamide levels in the foods under consideration are
being sampled repeatedly in a random way. During each
sampling round across these databases, intake data from
the subjects are being linked to contamination data,
thereby generating series of theoretically occurring
acrylamide intakes on individual level.
Mathematically, a subjects usual daily acrylamide in-
take is computed according to the equation:
Σ Σ
ΣΣ
Σ Σ
Fig. 1. Graphical presentation of the one-dimensional Monte Carlo simulation model used in the current paper.
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ðX v;i;tCv;i;tÞ=Twhere Xv,i,t is the amount (g) of relevant acrylamide con-
taining food item v (see above), consumed by subject i,
at day t (t = 1, . . . ,T) and Cv,i,t is the concentration of
acrylamide in a food item, expressed by lg/kg food stuﬀ,
randomly chosen.
For each subject i, the average body weight adjusted
daily intake via food of acrylamide (DIi) is computed
according to the equation: DIi = Yi/bwi, where Yi is
the subjects average total daily intake of acrylamide
and bwi is body weight (kg).
Sampling rounds across databases are being repeated
in the same way until saturation is reached, i.e., until
further sampling does not add measurably to the avail-
able information.
For the purpose of optimising integration of respec-
tively the intra-individual and inter-individual variabil-
ity in food consumption in the overall exposure
assessment model, the 7-day diary was extended to a ﬁc-
tive 75 day diary for all subjects (by simply copying the
diary repeatedly until 75 days are reached) and the num-
ber of subjects was artiﬁcially extended to 1500 (by ran-
domly copying subjects until the target number was
reached).
The former procedure thereby increases the likeli-
hood of combining all existing food combinations and
portions in the diaries with all available contamination
values for these foods. The latter procedure accounts
predominantly for the uncertainty arising from a rela-
tively small sample size.
Finally, the above described procedure has been re-
peated in 200 consecutive loops, yielding 200 theoretical
distributions of acrylamide intake. The median distribu-
tion from these 200 obtained distributions is the one
ﬁnally reported in this paper. All simulations presented
were run using the Hexalog software (Aardex Ltd.).2.3. Reference doses and cancer slope factors
A Joint FAO/WHO Consultation recognized neuro-
toxicity as the key non-cancer, non-genotoxic eﬀect of
acrylamide in humans (FAO/WHO, 2002). A No Ob-
served Adverse Eﬀect Level (NOAEL) for acrylamide-
induced neuropathy was identiﬁed as 0.5mg/kg body
weight/day in a chronic rat experiment (Spencer and
Schaumburg, 1974). Based on that life long experiment,
an oral reference dose (RfD) of 5lg/kgbw/d can be cal-
culated—by dividing the NOAEL by an assessment fac-
tor (AF) of 10 · 10 for inter-species and intra-species
extrapolation—following the conventional EU proce-
dure to determine an acceptable daily intake for pesti-
cides in food and in analogy with the US-EPA
procedure given below. It can be assumed that an intake
below this reference dose of 5lg/kgbw/d will be without
appreciable risk for neurotoxic health eﬀects in man.
The US-EPA (1993), however, based its risk assess-
ment on neurotoxic eﬀects observed in subchronically
exposed rats (Burek et al., 1980), where a No Observed
Eﬀect Level (NOEL) of 0.2mg/kgbw/d was identiﬁed.
Applying an AF of 10 · 10 · 10 (for inter-species,
intra-species, and subchronic to chronic extrapolation),
they calculated an oral RfD of 0.2lg/kgbw/d for this
non-carcinogenic eﬀect (US-EPA, 1993). This approach,
therefore, identiﬁes a signiﬁcantly lower intake below
which it is assumed that no appreciable neurotoxic
eﬀects will occur in man.
Acrylamide has been shown to be clastogenic and
carcinogenic in the animal (Friedman, 2003). It is classi-
ﬁed as a probable human carcinogen (IARC, 1994; US-
EPA, 1993) or as a substance, which should be regarded
as if carcinogenic to man (http://ecb.jrc.it/classiﬁcation-
labelling/) (European Commission, 2002b). Within the
EU regulatory framework, no quantitative risk estima-
tion is performed for that kind of substances and intake
should remain as low as possible. Starting from life long
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produce cancer in 25% of the animals exposed can be
calculated and a linear extrapolation towards zero can
be performed. This leads to an oral cancer slope factor
(CSF) applicable to man of 1.6 (mg/kgbw/d)1 (Dybing
and Sanner, 2003). This predicts that the number of
extra cancers caused over a lifetime is equal to the daily
acrylamide dose multiplied by 1.6 (mg/kgbw/d)1, e.g., a
daily intake of 1lg/kg body weight/day could produce
1.6 extra-cancers per 1000 men exposed. Applying a lin-
earised multistage (LMS) model to the animal experi-
mental data, the US-EPA (1993) derived an oral
cancer slope factor (CSF) for man of 4.5 (mg/kgbw/
d)1 (US-EPA, 1993). Similar estimations regarding in-
take via water, led to drinking water unit risks of 1.3
(lg/l)1 (US-EPA, 1993) or 5 (lg/l)1 (WHO, 1996).3. Results
3.1. Intake estimation
In Table 1 the acrylamide levels (lg/kg) in various
food groups are shown. The levels of acrylamide varied
considerably between single food items within food
groups. In Table 1 the food consumption of the food
groups used in the intake calculations are shown.
Fig. 2 shows the cumulative distribution function of
the total acrylamide. The exposure to acrylamide via
food in the total Flemish adolescent group ranges from
0.19lg/kgbw/d at the 5th percentile, over 0.51lg/kgbw/
d at the 50th percentile, to 1.09lg/kgbw/d at the 95th
percentile. For boys the range varies from 0.23 (P5) over
0.64 (P50) to 1.26 (P95) lg/kgbw/d, and for girls from
0.17 (P5) over 0.46 (P50) to 0.94 (P95) lg/kgbw/d.
Fig. 2 also shows the distribution of the intake via diﬀer-
ent food groups. The percentile distribution for each
food group is estimated independently. Therefore, theTable 1
Acrylamide amounts (lg/kg) of food groups and consumption (g/day) of th
Contamination data (lg/kg food stuﬀ)
Number of samples Median (Min–Max)
Babys biscuits 5 324 (225–1217)
Bread 6 30 (27–36)
Small bread type 4 38 (29–51)
Crisps 29 676 (38–1612)
Chocolate 3 108 (104–109)
Choco-spread 2 88.5 (65–112)
French fries 33 254 (56–729)
Biscuits 6 143 (20–1514)
Coﬀee 11 114 (11–1291)
Gingerbread 5 1403 (108–1697)
Breakfast cereals 20 135 (37–623)
Popcorn 5 160 (129–216)
Sweet spiced biscuit 5 204 (160–677)total intake at a certain percentile is diﬀerent from the
sum of the diﬀerent food items at that percentile.
The separate analysis for each food group or food
item separately, indicates that bread is the most impor-
tant contributor of background acrylamide-intake for
the lower percentiles (up to the 21st percentile). From
the 21st percentile French fries are the main source of
acrylamide exposure. From the 55th percentile on, bis-
cuits are the second important source of acrylamide in-
take. For the subgroups with higher intakes, above the
93rd percentile, French fries, crisps, biscuits, breakfast
cereals and coﬀee (in order of importance) become the
more important sources of acrylamide. Other food
items, such as popcorn, chocolate, choco-spread, ginger-
bread and sweet spiced biscuit, contribute little to the
total exposure via food (Table 2).
3.2. Intake and health based exposure limits
The intakes shown in Fig. 2, including the highest
99th percentile of intake, i.e., for boys, 1.41lg/kgbw/d,
are lower than the dose of 5lg/kgbw/d below which
neurotoxic eﬀects in man would be negligible (see Sec-
tion 2). They are, however, all above the US-EPA
RfD for neurotoxicity of 0.2lg/kgbw/d.
On the basis of the CSF of 1.6 (mg/kgbw/d)1 (Dyb-
ing and Sanner, 2003), a lifetime cancer cumulative inci-
dence in our population would vary from 2.9 · 104 for
an acrylamide intake at 0.18lg/kgbw/d (3rd percentile),
over 8.2 · 104 at 0.51lg/kgbw/d (50th percentile), up
to 17.4 · 104 at 1.09lg/kgbw/d (95th percentile).4. Discussion
The median dietary acrylamide intake in Flemish
adolescents can be estimated to be 0.51lg/kgbw/d.
The 95th percentile of intake is 1.09lg/kgbw/d. Bothose food groups in adolescents
Consumption data (g/day)
All (n = 341) Boys (n = 129) Girls (n = 212)
Mean (P50–P95) Mean (P50–P95) Mean (P50–P95)
1.97 (0–15) 1.20 (0–0) 2.44 (0–25)
119.30 (100–315) 146.45 (135–360) 102.77 (90–265.63)
44.31 (0–200) 47.65 (0–207.60) 42.28 (0–192.50)
5.93 (0–45) 7.91 (0–60) 4.72 (0–30)
9.73 (0–50) 12.34 (0–60) 8.14 (0–50)
7.64 (0–40) 10.30 (0–60) 6.02 (0–30)
39.88 (0–250) 45.84 (0–300) 36.26 (0–200)
17.51 (0–83) 19.11 (0–90) 16.53 (0–79.75)
44.90 (0–300) 46.25 (0–300) 44.07 (0–293.75)
0.88 (0–0) 1.75 (0–0) 0.35 (0–0)
9.17 (0–60) 13.79 (0–75) 6.36 (0–40)
0.14 (0–0) 0.06 (0–0) 0.19 (0–0)
1.49 (0–14) 2.17 (0–21) 1.08 (0–0)
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Fig. 2. Cumulative distribution functions in the background intake of acrylamide (lg/kgbw/day). The cumulative distribution functions for total
intake and for the intakes via diﬀerent food items are estimated separately. Therefore, the total intake at each percentile is not equal to the sum of the
intake via the individual food items.
Table 2
Variation in simulated daily acrylamide exposure in the adolescent population, via French fries, crisps, bread and in total
Percentile Via French fries
(lgAA/kgbw/day)a
Via crisps
(lgAA/kgbw/day)a
Via bread
(lgAA/kgbw/day)a
Via biscuit
(lgAA/kgbw/day)a
Total exposure
(lgAA/kgbw/day)a
1 0 0 0.002 0 0.108
5 0 0 0.013 0 0.185
20 0 0 0.034 0.004 0.327
50 0.155 0 0.057 0.055 0.513
55 0.171 0 0.063 0.064 0.545
75 0.276 0.087 0.081 0.111 0.702
95 0.521 0.298 0.127 0.260 1.089
99 0.725 0.596 0.159 0.459 1.411
a AA: acrylamide and bw: body weight.
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girls. This is explained by the fact that boys have a high-
er intake of food than girls. Our study addresses the
adolescent population since in Belgium, up to date, de-
tailed consumption data for people older than 18 years
of age are lacking. At a Joint FAO/WHO Consultation
it was stated that the average intakes for the general
population were estimated to be in the range of 0.3–
0.8lg acrylamide/kg bw/d. In Sweden, a median dietary
intake of acrylamide of approximately 0.38lg/kgbw/d
and a 95th percentile intake of 0.89lg/kgbw/d (assum-
ing a body weight of 70kg) was calculated for 1211 indi-
viduals between 18 and 74 years old (Svensson et al.,
2003). In Norway the median acrylamide exposure var-
ied from 0.41 to 0.42lg/kgbw/d, respectively males andfemales between 16 and 79 years old. In Norwegian 13
years old youngsters the median exposure varied from
0.30 to 0.28lg/kgbw/d, respectively for boys and girls
(Dybing and Sanner, 2003). In the Netherlands the med-
ian exposure of acrylamide for 7–18 years children was
estimated to be 0.2lg/kgbw/d and the 95th percentile
was 0.9lg/kgbw/d (Konings et al., 2003). Based on a
duplicate diet study, the mean acrylamide exposure in
a Swiss population (16–67 years) was 0.28lg/kgbw/d
(Swiss Federal Oﬃce of Public Health, 2002). Based
on the USDA Continuing Survey of Food Intake for
Individuals an average acrylamide exposure of 0.8lg/
kgbw/d was estimated (Petersen, 2002). It appears
that the acrylamide intake by Flemish adolescents is of
the same order as that in other developed countries.
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fact that diﬀerent subpopulations were included and
that diﬀerent methodologies were applied, e.g., diﬀerent
food consumption questionnaires, diﬀerent models, and
probably the inclusion of more food items because of
the extrapolation of analytical data among related food
items. As in other studies (Sweden, Norway, the Nether-
lands) the most important solid food sources are French
fries and related potato products, the consumption of
which may be higher in our country than in others (Dyb-
ing and Sanner, 2003; Konings et al., 2003; Svensson
et al., 2003). Bread contains a low amount of acrylamide
but is the most important contributor in the lower per-
centiles. This could be explained by the relatively large
daily consumption of this food group in Belgium. Coﬀee
contributes considerably in the higher percentiles of the
acrylamide intake. Compared to an adult population,
however, the coﬀee consumption in our adolescents re-
mains rather low; in an adult setting coﬀee would be-
come more important. Swedish and Norwegian studies
indeed revealed the high contribution of coﬀee in the in-
take of acrylamide by adult populations (Dybing and
Sanner, 2003; Svensson et al., 2003).
It must be emphasized that, for several reasons, the
exposure assessment presented here has several limita-
tions. The exposure assessment is still based on a limited
number of analytical measurements in a limited number
of food items and samples. This is only partially remedi-
ated by the extrapolation of analytical results to strongly
related food items that were not analysed for acrylam-
ide. Based on the ﬁndings of Konings and co-workers,
the impact of this extrapolation would be rather small
(Konings et al., 2003). The choice to introduce into
the model a value of one third of the limit of quantita-
tion, for concentrations below the limit of quantitation,
might lead to an under or over estimation of the acryl-
amide intake. French fries, which are important contrib-
utors to the total intake, are mainly processed at home
at variable conditions and it is known that the acrylam-
ide content is highly aﬀected by frying temperature and
frying time (Tareke et al., 2002). No analyses, however,
were carried out on home prepared food and no uncer-
tainties were introduced in the model to take this into
account. Finally, the issue of under-reporting can not
be neglected. Several studies have shown that under-
reporters have a speciﬁc pattern of under-recording
(Heitmann and Lissner, 1995; Lafay et al., 2000).
Snack-type foods are preferentially forgotten in food
questionnaires and food items rich in fat and/or carbo-
hydrates (such as butter, French fries, sugars and con-
fectionery, cakes and pastries) are reported less
frequently and/or in smaller quantities than actually
consumed. Due to the lack of complementary data
(e.g., the eﬀect of home processing) and the unavailabil-
ity of a valid indicator to detect adolescent under report-
ers, it remains diﬃcult to predict the total impact of allthese factors on the intake assessment; it is almost cer-
tain that the real intake in most studies, as in ours, is
higher than calculated.
For risk assessment purposes, the length of time over
which dietary samples are to be collected is several con-
secutive days at multiple intervals of months, seasons
and years (Kroes et al., 2002). In the present study,
the only existing, available food consumption data-set,
which was collected for other purposes, is used. The
population was followed during 7 days and included
all foods and beverages consumed at meals and in be-
tween, in quantiﬁed amounts. In general, it is accepted
that a 7-day dietary record represents a habitual intake.
However, in exposure assessment no consensus is
achieved to the time frame to be used in the assessment
of intake of food chemicals (Kroes et al., 2002). On the
other hand, it was found that the diet history method is
probably the best choice, followed by dietary records, to
estimate exposure to food additives (Lowik, 1996). Nev-
ertheless, various strategies for exposure calculation can
be achieved depending on the nature of the available
data; this is extensively described by Kroes et al.
(2002). In the current study, a one-dimensional Monte
Carlo has been executed. Individual food consumption
distributions and food contamination distributions were
used in the model. In the current method, the informa-
tion on the input variability is passed on through the
model to the output.
A quantitative estimation of the risk for adverse
health eﬀects in our population, on the basis of the esti-
mated intake of acrylamide and health based exposure
limits (oral reference doses), remains fraught with uncer-
tainty. Indeed reference doses calculated for non-carcin-
ogenic endpoints predict that intakes below these will
not be accompanied by appreciable toxicity in man. In-
takes slightly above these reference limits may be accom-
panied by adverse health eﬀects, but quantitative ﬁgures
are nearly impossible to estimate. An estimation of the
risk for neurotoxic eﬀects in our population heavily de-
pends on the choice of the reference dose, 5lg/kgbw/d
or 0.2lg/kgbw/d, depending on the reference experi-
ment and assessment factors chosen (see methodology).
Accordingly, no or small, undeﬁned neurotoxic eﬀects
would be predicted at the estimated intake levels. It
seems rather unlikely that even a detailed, controlled
epidemiological study performed in the high intake
group might be able to detect neuronal eﬀects that can
be undeniably attributed to acrylamide intake via food.
Neurotoxicity has been observed in occupational studies
(Hagmar et al., 2001; He et al., 1989; Marsh et al., 1999)
but exposure was almost certainly substantially higher.
A similar caution should be applied when deducing
extra-cancer numbers in our population as a result of
the estimated acrylamide intakes and its CSF. As shown
above, CSFs may be quite diﬀerent depending on the
data used and procedure followed. Furthermore, in the
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lated according to a worst case approach. The actual
cancer risk in man may be much lower or even zero
(Crump, 1996; Lovell and Thomas, 1996). The LMS
model (US-EPA) was indeed developed for regulatory
purposes and not to predict cancer numbers in a parti-
cular situation (Crump, 1996).
Until now, epidemiological studies found no associa-
tion between consumption of foods containing acrylam-
ide and cancer risk (Erdreich and Friedman, 2004;
Mucci et al., 2003, 2004; Pelucchi et al., 2003). However,
epidemiological studies have limited power to detect
small increases in tumour incidence. Negative epidemio-
logical studies may therefore provide an upper-bound to
possible carcinogenic eﬀects, rather than proof that no
such eﬀects exist (FAO/WHO, 2002). However, Granath
and Tornqvist (2003) concluded that acrylamide can
contribute approximately 1% of the lifetime cancer risk,
considering that a large fraction of all cancers has been
attributed to dietary factors (American Cancer Society,
1999; Granath and Tornqvist, 2003).
Biomarkers of acrylamide exposure have been re-
ported and estimated a background level (non-smoker)
of 1.43lg/kgbw/d (assuming a body weight of 70kg)
(Svensson et al., 2003). Based on our ﬁndings and obser-
vations in the literature, the estimated dietary intake can-
not explain the overall acrylamide exposure. Non-food
acrylamide exposures may be substantial for some popu-
lations (FAO/WHO, 2002). Other sources of acrylamide
are cosmetics, drinking water, packaging materials and a
possible endogenous formation in the body and also cig-
arette smoke (active and passive) and occupational expo-
sure (European Commission, 2002b). Nevertheless, a
reduction of acrylamide content in food could still con-
tribute to a decrease of total acrylamide exposure, cer-
tainly at the higher percentiles of intake, supposing
that all other intermediate factors are kept constantly.
Strategies to reduce the acrylamide content of food
have been proposed by the European Commission after
a workshop with the member states and stakeholder
organisations in October 2003 (European Commission,
2003), by Friedman (2003) and at the Acrylamide in
Food Workshop (JIFSAN/ NCFST).
Meanwhile, because of undeﬁned, although quite
low, risks for neurotoxic eﬀects and carcinogenic po-
tency of acrylamide, its intake should be as low as pos-
sibly achievable. People should be advised to avoid
excessive frying of baking, especially with regard to po-
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